Found 6 matching trials
Serplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma
PHASE2China with high incidence of esophageal cancer, the number of new cases and...
Status
Active Not Recruiting
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Neoadjuvant Ivonescimab(AK112) Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma
PHASE2In the past few decades, surgery, radiotherapy, chemotherapy and other trea...
Location
The Second Affiliated Hospital of Zhejiang University
Carrelizumab, Chemotherapy and Apatinib in the Neoadjuvant Treatment of Resectable Esophageal Squamous Cell Carcinoma
PHASE2China with high incidence of esophageal cancer, the number of new cases and...
Status
Active Not Recruiting
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Adbelimumab Combined With Chemotherapy and Apatinib in Patients With Resectable Esophageal Squamous Cell Carcinoma
PHASE2Esophageal cancer is a prevalent digestive tract tumor, with around 400,000...
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Camrelizumab, Chemotherapy and Ivarmacitinib in Patients With Resectable Esophageal Squamous Cell Carcinoma
PHASE2In the management of locally advanced esophageal squamous cell carcinoma, t...
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Serplulimab Combined With Chemotherapy in Patients With Resectable Non-small-cell Lung Cancer
PHASE2China with high incidence of non-small cell lung cancer. In the past few de...
Status
Active Not Recruiting
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University